Michael Schwab is a business development leader with over 20 years of experience in business insights, analytics, and strategy. He has held leadership roles at Blueprint Medicines and Genzyme, driving commercial success through product launches and portfolio planning. Michael spent the earlier part of his career at Health Advances, a renowned strategy consulting firm. Currently, Michael serves as the Head of Strategic Insights and Analytics for Servier Pharmaceuticals. 

 

Michael has a degree in Biotechnology from Dartmouth, a masters in engineering from Northwestern University, as well as an MBA from Northwestern’s Kellogg School of Management. Michael specializes in building high-performing teams and shaping strategies for transformative therapies.